Objectives-To determine the quantitative topographical distribution of cathepsin B in human femoral head cartilage by measuring the zonal variation of enzyme activity in specimens taken from various anatomical regions of normal and osteoarthritic (OA) tissues, and to correlate this parameter with the severity of the OA lesions. Methods-OA articular cartilage was obtained at surgery for total hip replacement and control cartilage obtained at postmortem. Cylinders of full thickness cartilage with underlying bone were retrieved with a biopsy trephine. Sections of cartilage were produced by cryocutting the tissue as slices parallel to the articular surface and assayed for cathepsin B with a specific, highly sensitive fluorogenic substrate. at the bone side to a cork disk, using a small drop of Tissue-Tek® OCT compound (Miles, IN, USA), frozen in a quick freeze carbon dioxide chamber and stored at -70°C. The specimens were allowed to reach the cabinet temperature of -25°C before being cryosectioned as 20 ,um thick slices parallel to the articular surface. This is a modification of a previously published method.26 Five consecutive sections were collected in conical, 1 ml Eppendorfer vials until the subchondral bone was reached, and left at -25°C. Five sections obtained as described have a volume of 1-26 mm3 and an area of 126&9 mm2, whereas a single, 100 pum thick section would have the same volume, but an area of only 26-4 mm2.
regenerating cartilage, where some zonal peaks attained 20-fold activity with respect to controls.
Conclusion-Cathepsin B may play a role in sustainiing the chronicity of OA, not as an initiator, but rather as a perpetuator of the disease and as an antagonist of regeneration.
(Ann Rheum Dis 1995; 54: [281] [282] [283] [284] [285] [286] [287] [288] Chondrocyte mediated breakdown of cartilage has classically been studied in the context of cell stimulation by cytokines.1 2 Matrix degradation has been attributed to metalloproteinases stimulated by cytokines from synovium,3 monocyte-macrophage lineage cells,4 or polymorphonuclear leucocytes,5 or of autocrine origin.6 A rich literature and modem trends in the pathophysiology of articular cartilage have been comprehensively reviewed. 7 8 Enzymes other than metalloproteinases have received less attention, but the discovery that endogenous hydrolases are responsible for cartilage autodegradation9 10 stimulated research on the possible pathological significance of this phenomenon." 12 Cathepsin B and cathepsin D are able to degrade both collagen and aggrecan in vitro,'3-'" but cathepsin D, although present at extracellular sites in rheumatoid synovium,16 is not responsible for the resorption of cartilage in organ culture.'7 Despite higher levels of cathepsin D in osteoarthritis (OA) compared with normal cartilage, 18 19 its action is restricted to intracellular catabolism of matrix macromolecules within chondrocytes. 20 Increased concentrations of cathepsin B have been demonstrated in rheumatoid synovium1621 22 and synovial fluid,2' 2325while much smaller amounts were found in OA synovial fluid. 24 25 Increased concentrations of cathepsin B in human OA cartilage18 26 27 were accompanied by a decrease in cysteine endopeptidase inhibiting activity in severely damaged tissue. 27 Chondrocytes can be stimulated to increase dramatically the synthesis, storage, and secretion of cathepsin B through modulation of their differentiated phenotype to a more primitive one. 28 This property is reversible: cathepsin B levels revert to normal after the phenotype is modulated back to its original state. 28 29 After stimulation with interleukin-1l, cathepsin B biosynthesis and storage are slightly increased, while secretion is not. 30 We describe below zonal variations of cathepsin B activity in normal and OA human articular cartilage and suggest that this enzyme may play a pathological role by sustaining and perpetuating the OA process.
Materials and methods

CARTILAGE
Femoral heads were obtained from patients who underwent total hip replacement for both primary and secondary OA. After resection, the specimens were immediately immersed in sterile Hank's balanced salt solution supplemented with penicillin 50 IU/ml and streptomycin 50 ,ug/ml, and processed within two hours. Control femoral heads were obtained at postmortem, usually four to five hours, but never in excess of eight hours, after death, immediately placed in Hank's balanced salt solution with penicillin-streptomycin (as above) and amphotericin B 2-5 ,ug/ml, and processed within 30 artificial loss of proteoglycans during preparation for paraffin embedding, cartilage samples (either cylinders obtained as described above, or slices with underlying bone resected from the area between two adjacent holes produced for cylinder extraction) were snap frozen and cryosectioned at a thickness of 14-18 ,um. After 15 minutes fixation with 4% formaldehyde in 0-1 mol/ sodium phosphate buffer, pH 7 4, sections were rinsed with this buffer, brought to 50% and then to 80% ethanol (five minutes each), and sequentially stained with Weigert's iron chloride haematoxylin, fast green FCF, and safranin 0 before being permanently mounted.34 Under these conditions glycosaminoglycans were stained by safranin 0 in the orthochromatic form35 and their loss was made visible by the presence of the green counterstain. The only disadvantage of this method is that the subchondral bone may be damaged in some sections and the tidemark integrity could not be evaluated.
CATHEPSIN B ASSAY
The frozen cartilage sections were thawed rapidly to disrupt cells by suspending them in 0 50 ml of 0-10 mmol/l Z-Arg-Arg-NMec After incubation at 37°C under gentle shaking for exactly four hours the reaction was stopped with 10 iil of 0-1 molIl iodoacetamide in water.
The fluorescence of liberated 7-amino-4-methylcoumarin was read in an Aminco SPF-500 fluorimeter operating in the ratio mode with excitation and emission wavelengths set at 383 and 455 nm, respectively. The recorder scale was calibrated with 7-amino-4-methylcoumarin solutions of known concentration determined using an absorption coefficient of 16 000 mol-11 cm-' at 342 nm for this substance. The described assay was optimised in preliminary experiments using cartilage specimens with high and low cathepsin B activities, and using purified human spleen cathepsin B.37 In order for the reaction to be linear with time and enzyme concentration, an excess of substrate was ensured.
Z-Arg-Arg-NMec is a substrate with high specificity for cathepsin B; it does not react with cathepsin H38 and has only trace activity with cathepsin L.39 Possible interference by these cysteine endopeptidases or other enzymes was excluded by control studies. For this purpose, four adjacent plugs of cartilage were taken from a region of an OA femoral head with uniform thickness. Two plugs were used to determine the uniformity of the zonal variation of cathepsin B activity and two plugs were used to determine the effect of inhibitors included in the assay solution in alternate samples. The inhibitors used were 3,4-dichloroisocoumarin, L-trans-epoxysuccinylleucylamido-(4-guanidino)-butane (E-64) (Sigma, St Louis, MO, USA), Z-Phe-Ala-CHN2, Z-Phe-Phe-CHN2, Pro-Phe-Har-CH2 Cl (a gift of Dr E Shaw, Basle, Switzerland), and leupeptin (Bachem Ltd).
One unit of cathepsin B activity was defined as the amount of enzyme that hydrolysed 1 nmole of substrate in four hours at pH 6-0 and 37°C. The five consecutive sections were pooled for analysis. Actual concentrations of 7-amino-4-methylcoumarin released in the assay were in the range 0-2-80 ,umo1l/, thus allowing accurate readings with any commercial fluorimeter. This method allowed the topographical mapping of cathepsin B in the cartilage of a whole joint to show its quantitative distribution in the various zones.
Both thiol activation (by DTT) and the presence of EDTA were necessary to ensure measurement of cathepsin B activity. In the control studies for assay specificity, the activity was completely abolished by Pro-Phe-Har-CH2 Cl, a potent inhibitor of cathepsin B,40 and by leupeptin. Good inhibition was obtained with Z-Phe-Ala-CHN2, and E-64, whereas no inhibition was observed with Z-Phe-Phe-CHN2 or with the general serine endopeptidase inhibitor 3,4-dichloroisocoumarin.41 These data (fig 2) confirmed the cysteine endopeptidase character of the measured enzyme and are highly characteristic of cathepsin B. 38 Cathepsin B activity in zones of normal cartilage (type I) never exceeded seven units/ sample (fig 3) . Activity as a function of the distance from the subchondral bone was quite regular, generally greater towards the articular surface (zone I) and lower in the mid zones (II and III). In the deeper zones (IV and V), catheptic activity was either the same as observed in the central zones, or slightly greater. Cell density in zones of articular cartilage is greater in the superficial layer than in the mid and deep zones, where it is quite uniform.42 Zonal variations of cathepsin B activity in normal cartilage can thus be attributed to cell heterogeneity, different metabolism, and different density. As already suggested,26 greater activity in the superficial layer is a property of the fibrocyte type chondrocytes of this zone. Type III cartilage, obtained from elderly subjects (controls 6 and 8 in figure 3 ) was not fibrillated and was still considered to be 'normal' on the basis of macroscopic morphology, the only difference 20 The dependence of the normalised activities upon the anatomical site within the femoral head is shown in figure 7A , together with the cartilage type. In normal subjects cathepsin B activity was similar in the four regions of the femoral head: the mean values for the posterior, anterior and inferior regions were statistically indistinguishable from one another, while the superior region had significantly less activity than the others (p = 0-0041 compared with posterior). The The data of figure 7A are plotted as a function of age in figure 7B , in which the lack of correlation between cathepsin B activity and donor's age in the cartilage types I and III is evident. OA cartilages from relatively young subjects had the greatest activities and a large proportion of typical OA samples from elderly subiects had activities comoarable to those of the controls. The slope of thI nificantly different from zero, e curve, sig-inverse correlation between enzyme activity suggests an and age in the OA group. Figure 8 shows the dependence of cathepsin B activity on cartilage type using all pooled data. With cartilage type I as the reference, the ** * other types showed significantly higher A activities, although the difference between the means of types I (2-7 (SD 0-8)) and III (3-5 (0-8)) was small. The histological-histochemical grade of the OA lesions33 was determined for all of the patients and controls represented in figures 4 1 * 3-6, in at least one cartilage specimen immediately adjacent to a plug analysed for cathepsin B activity (fig 9) . Many more samples were analysed than are shown here; for q ,e all of them, structure, cellularity, and safranin 0 staining could be determined and these data were used for evaluation. For reasons ex-P A plained in the Methods section, it was not Dsteoarthritic always possible to judge tidemark integrity of the samples; figure 9 shows the samples for which all four parameters could be unequivocally determined. The mean cathepsin B activity in all pooled data of residual cartilage (type IV) was only slightly greater than that of normal (type I) cartilage because the activity of a large proportion of the type IV specimens was in the range of the controls, despite clear signs of OA. While this is an effect of data pooling, we stress the importance of individual evaluation of zonal cathepsin B distribution for identifying focal sites of high activity. Type IV cartilage represents the old, residual tissue that may show all possible stages of degradation, from an almost intact structure to complete disorganisation. Type IV samples with low grade destruction, almost normal cellularity, slightly impaired safranin 0 staining in the superficial or deeper zones, and undamaged tidemark, had low Mankin scores and low cathepsin B levels. This cartilage can be considered to represent a tissue in an initial phase of OA. Other type IV specimens showed clear signs of degeneration, hypercellularity or cloning, impaired safranin staining, tidemark destruction without duplication, and high cathepsin B activity. We consider this cartilage as representative of active OA in a destructive phase, but not yet with a reparative reaction. The type IV cartilage specimens with clear signs of degeneration and low levels of cathepsin B were either hypocellular or hypercellular, but with many remnants of chondrons and cell clusters containing highly degenerated, atrophied, and possibly dead cells. The overall structure of these specimens was from irregular to completely disorganised, with severely reduced safranin 0 staining and the tidemark duplicated, triplicated, or damaged. This cartilage, representing a highly degenerated tissue with a past history of active disease, thus had high histological scores and low cathepsin B levels.
The greatest enzyme activities were found in type V cartilage and in those specimens having cartilage type V overgrowing type IV. Ihese samples had zonal cathepsin B activities that were up to 20-fold greater than those found in corresponding zones of control cartilage. Histological analysis suggested that particularly high activity was present in zones where hyperactive chondrocytes were involved in the reparative processes by synthesising cartilage of a 'juvenile' type.26 At these sites the chondrocytes were in clusters within a completely disorganised interterritorial matrix showing strong pericellular safranin 0 staining. These cartilage specimens covered a broad spectrum of cathepsin B activities that were always greater than controls, and a broad range of histological scores.
The distribution of enzyme activity in OA cartilages with various degrees of degeneration suggests a pathological role for cathepsin B. The relatively low activities in apparently intact and severely degraded OA cartilages, in contrast with high levels in tissues with active disease and at regenerating sites, suggest that cathepsin B may act as a perpetuator rather than an initiator of cartilage destruction in OA and may be at least partly responsible for unsuccessful tissue repair. This concept is supported by cytochemical and histochemical results discussed in the accompanying paper.44
